Filed: 2/14/2025ACC: 0001011438-25-000175
📋 What this filing means
INDABA CAPITAL MANAGEMENT, L.P. filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $207.55M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$207.55M
Total AUM (reported)
159.18M
Total Shares
Allocation by class
COM SHS$40.28M19.4%
COM$33.99M16.4%
NOTE 0.500% 4/0$32.17M15.5%
NOTE 1.750% 2/1$24.03M11.6%
NOTE 1.500% 2/1$21.97M10.6%
COM SH BEN INT$16.90M8.1%
NOTE 1.500% 6/1$13.04M6.3%
Portfolio Concentration
Top 3$99.84M48.1%
4–10$107.71M51.9%
Top 3 weight
48.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 159.18M
Sole
Full voting authority
159.18M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
BLUE OWL CAP CORP III
SOLEShares2.79M
TypeSH
Market value$40.28M
19.41%
Sole
2.79M
Shared
0.00
None
0.00
BANDWIDTH INC
SOLEShares40.25M
TypePRN
Market value$32.17M
15.50%
Sole
40.25M
Shared
0.00
None
0.00
ON24 INC
SOLEShares4.24M
TypeSH
Market value$27.39M
13.20%
Sole
4.24M
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares25M
TypePRN
Market value$24.03M
11.58%
Sole
25M
Shared
0.00
None
0.00
SUMMIT HOTEL PPTYS
SOLEShares22.66M
TypePRN
Market value$21.97M
10.58%
Sole
22.66M
Shared
0.00
None
0.00
EQUITY COMWLTH
SOLEShares9.55M
TypeSH
Market value$16.90M
8.14%
Sole
9.55M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares14M
TypePRN
Market value$13.04M
6.28%
Sole
14M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares13M
TypePRN
Market value$12.83M
6.18%
Sole
13M
Shared
0.00
None
0.00
ACCELERATE DIAGNOSTICS INC
SOLEShares24.69M
TypePRN
Market value$12.34M
5.95%
Sole
24.69M
Shared
0.00
None
0.00
ESPERION THERAPEUTICS INC NE
SOLEShares3M
TypeSH
Market value$6.60M
3.18%
Sole
3M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BLUE OWL CAP CORP IIISOLE | COM SHS | 2.79M | SH | $40.28M 19.41% | 2.79M | 0.00 | 0.00 |
BANDWIDTH INCSOLE | NOTE 0.500% 4/0 | 40.25M | PRN | $32.17M 15.50% | 40.25M | 0.00 | 0.00 |
ON24 INCSOLE | COM | 4.24M | SH | $27.39M 13.20% | 4.24M | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | NOTE 1.750% 2/1 | 25M | PRN | $24.03M 11.58% | 25M | 0.00 | 0.00 |
SUMMIT HOTEL PPTYSSOLE | NOTE 1.500% 2/1 | 22.66M | PRN | $21.97M 10.58% | 22.66M | 0.00 | 0.00 |
EQUITY COMWLTHSOLE | COM SH BEN INT | 9.55M | SH | $16.90M 8.14% | 9.55M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | NOTE 1.500% 6/1 | 14M | PRN | $13.04M 6.28% | 14M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 13M | PRN | $12.83M 6.18% | 13M | 0.00 | 0.00 |
ACCELERATE DIAGNOSTICS INCSOLE | NOTE 5.000%12/1 | 24.69M | PRN | $12.34M 5.95% | 24.69M | 0.00 | 0.00 |
ESPERION THERAPEUTICS INC NESOLE | COM | 3M | SH | $6.60M 3.18% | 3M | 0.00 | 0.00 |